Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2023 Filed Nov 14, 2023 22:28 UTC |
Nagel Bradley M.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $10.25 | $0.00 |
DisclosureSEC source: 0001437749-23-032054 · rdgdoc.xml · derivative · entry 1 Nagel Bradley M. · CIK 0001954272 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2033-07-01 F1 · derivative.exercise_date: This stock option award vests in three substantially equal installments on each of June 30, 2024, 2025 and 2026. Read SEC document |
| July 12, 2023 Filed Jul 18, 2023 20:00 UTC |
SKARVAN KATHLEENDirector
|
SaleCommon Stock | 1,107 | $10.83 | $11,991.58 |
DisclosureSEC source: 0001437749-23-020139 · rdgdoc.xml · nonDerivative · entry 1 SKARVAN KATHLEEN · CIK 0001266296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,449 F1 · price: Reflects the weighted average price of 1,107 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on July 12, 2023 with purchase prices ranging from $10.71 to $10.9075 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:22 UTC |
Nagel Bradley M.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,900 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001437749-23-019427 · rdgdoc.xml · derivative · entry 2 Nagel Bradley M. · CIK 0001954272 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2033-07-01 F2 · derivative.exercise_date: 2,634 shares vest on June 30, 2024 and 2,633 shares vest on June 30, 2025 and June 30, 2026. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:22 UTC |
Nagel Bradley M.Chief Financial Officer
|
GrantCommon Stock | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-019427 · rdgdoc.xml · nonDerivative · entry 1 Nagel Bradley M. · CIK 0001954272 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,600 F1 · shares: Restricted Stock scheduled to vest in three equal annual installments starting on on June 30, 2024. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:21 UTC |
Cunniff James L.Director · CEO and President
|
GrantPerformance Stock Units · Derivative | 87,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-019426 · rdgdoc.xml · derivative · entry 3 Cunniff James L. · CIK 0001983687 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2027-06-30 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock upon achieving a total shareholder return in excess of 100% as of the end of any fiscal quarter on or before the expiration date, calculated using three-month volume-weighted average closing prices in accordance with the underlying agreement. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock upon achieving a total shareholder return in excess of 100% as of the end of any fiscal quarter on or before the expiration date, calculated using three-month volume-weighted average closing prices in accordance with the underlying agreement. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:21 UTC |
Cunniff James L.Director · CEO and President
|
GrantPerformance Stock Units · Derivative | 87,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-019426 · rdgdoc.xml · derivative · entry 2 Cunniff James L. · CIK 0001983687 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2027-06-30 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock upon achieving a total shareholder return in excess of 50% as of the end of any fiscal quarter on or before the expiration date, calculated using three-month volume-weighted average closing prices in accordance with the underlying agreement. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock upon achieving a total shareholder return in excess of 50% as of the end of any fiscal quarter on or before the expiration date, calculated using three-month volume-weighted average closing prices in accordance with the underlying agreement. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:21 UTC |
Cunniff James L.Director · CEO and President
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001437749-23-019426 · rdgdoc.xml · derivative · entry 1 Cunniff James L. · CIK 0001983687 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2033-06-30 F1 · derivative.exercise_date: Exercisable with respect to 43,750 shares on September 30, 2024, and in twelve substantially equal increments on the last day of each subsequent quarter. Read SEC document |
| February 27, 2023 Filed Mar 6, 2023 21:07 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001437749-23-005530 · rdgdoc.xml · derivative · entry 7 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2024-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| February 27, 2023 Filed Mar 6, 2023 21:07 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001437749-23-005530 · rdgdoc.xml · derivative · entry 6 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2023-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| February 27, 2023 Filed Mar 6, 2023 21:07 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
GiftCommon Stock | 40,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-005530 · rdgdoc.xml · nonDerivative · entry 4 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,556 F1 · shares: Transfer of shares to a family trust of which the reporting person serves as a trustee. Read SEC document |
| February 27, 2023 Filed Mar 6, 2023 21:07 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
Tax withholdingCommon Stock | 24,815 | $13.50 | $335,002.50 |
DisclosureSEC source: 0001437749-23-005530 · rdgdoc.xml · nonDerivative · entry 3 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,741 Read SEC document |
| February 27, 2023 Filed Mar 6, 2023 21:07 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
Exercise / conversionCommon Stock | 50,000 | $1.40 | $70,000.00 |
DisclosureSEC source: 0001437749-23-005530 · rdgdoc.xml · nonDerivative · entry 2 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 6, 2023 21:07 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
Exercise / conversionCommon Stock | 15,000 | $1.31 | $19,650.00 |
DisclosureSEC source: 0001437749-23-005530 · rdgdoc.xml · nonDerivative · entry 1 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 17:35 UTC |
Galatowitsch Joseph L.Director
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028444 · rdgdoc.xml · nonDerivative · entry 1 Galatowitsch Joseph L. · CIK 0001894945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2023, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:36 UTC |
Erickson Stan K.Director
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028446 · rdgdoc.xml · nonDerivative · entry 1 Erickson Stan K. · CIK 0001626702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,817 F1 · shares: Restricted Stock scheduled to vest on June 1, 2023, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:36 UTC |
Fluet GregoryDirector
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028445 · rdgdoc.xml · nonDerivative · entry 1 Fluet Gregory · CIK 0001438939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2023, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:35 UTC |
Lee A JonesDirector
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028443 · rdgdoc.xml · nonDerivative · entry 1 Lee A Jones · CIK 0001374449 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,183 F1 · shares: Restricted Stock scheduled to vest on June 1, 2023, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:34 UTC |
Summers AndrewDirector
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028442 · rdgdoc.xml · nonDerivative · entry 1 Summers Andrew · CIK 0001571767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2023, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:34 UTC |
Tune Kathleen ADirector
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028441 · rdgdoc.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2023, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Walsh Andrea M.Director
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028440 · rdgdoc.xml · nonDerivative · entry 1 Walsh Andrea M. · CIK 0001833129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2023, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 16:54 UTC |
Nagel Bradley M.Chief Financial Officer
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-027513 · rdgdoc.xml · nonDerivative · entry 1 Nagel Bradley M. · CIK 0001954272 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 21:40 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001437749-22-022443 · rdgdoc.xml · derivative · entry 5 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 21:40 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
GiftCommon Stock | 11,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-022443 · rdgdoc.xml · nonDerivative · entry 3 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,556 F1 · shares: Transfer of shares to a family trust of which the reporting person serves as a trustee. Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 21:40 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
Tax withholdingCommon Stock | 8,240 | $11.46 | $94,430.40 |
DisclosureSEC source: 0001437749-22-022443 · rdgdoc.xml · nonDerivative · entry 2 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,316 Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 21:40 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
Exercise / conversionCommon Stock | 20,000 | $1.75 | $35,000.00 |
DisclosureSEC source: 0001437749-22-022443 · rdgdoc.xml · nonDerivative · entry 1 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 19:51 UTC |
Wirtz Michelle C.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,700 | $0.00 Strike: $9.90 | $0.00 |
DisclosureSEC source: 0001437749-22-016761 · rdgdoc.xml · derivative · entry 2 Wirtz Michelle C. · CIK 0001932161 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,700 Underlying: Common Stock · 6,700 shares Expires 2032-06-30 F1 · derivative.exercise_date: Stock options scheduled to vest in substantially equal increments on each of June 30, 2023, 2024 and 2025. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 19:51 UTC |
Wirtz Michelle C.Chief Financial Officer
|
GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-016761 · rdgdoc.xml · nonDerivative · entry 1 Wirtz Michelle C. · CIK 0001932161 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 23:51 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,800 | $0.00 Strike: $9.90 | $0.00 |
DisclosureSEC source: 0001437749-22-016762 · rdgdoc.xml · derivative · entry 3 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,800 Underlying: Common Stock · 28,800 shares Expires 2032-06-30 F1 · derivative.exercise_date: Stock options scheduled to vest in equal increments on each of June 30, 2023, 2024 and 2025. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 23:51 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
GrantCommon Stock | 14,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-016762 · rdgdoc.xml · nonDerivative · entry 1 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,545 Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 23:50 UTC |
Holland Christopher G.Chief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,800 | $0.00 Strike: $9.90 | $0.00 |
DisclosureSEC source: 0001437749-22-016760 · rdgdoc.xml · derivative · entry 2 Holland Christopher G. · CIK 0001913383 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2032-06-30 F1 · derivative.exercise_date: Stock options scheduled to vest in substantially equal increments on each of June 30, 2023, 2024 and 2025. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 23:50 UTC |
Holland Christopher G.Chief Commercial Officer
|
GrantCommon Stock | 7,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-016760 · rdgdoc.xml · nonDerivative · entry 1 Holland Christopher G. · CIK 0001913383 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,900 Read SEC document |
| February 16, 2022 Filed Feb 25, 2022 14:59 UTC |
Holland Christopher G.Chief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,200 | $0.00 Strike: $12.11 | $0.00 |
DisclosureSEC source: 0001437749-22-004401 · rdgdoc.xml · derivative · entry 2 Holland Christopher G. · CIK 0001913383 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Underlying: Common Stock · 7,200 shares Expires 2032-02-15 F1 · derivative.exercise_date: Stock option vests in equal increments on each of February 15, 2023, 2024 and 2025. Read SEC document |
| February 16, 2022 Filed Feb 25, 2022 14:59 UTC |
Holland Christopher G.Chief Commercial Officer
|
GrantCommon Stock | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004401 · rdgdoc.xml · nonDerivative · entry 1 Holland Christopher G. · CIK 0001913383 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:06 UTC |
Galatowitsch Joseph L.Director
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027827 · rdgdoc.xml · nonDerivative · entry 1 Galatowitsch Joseph L. · CIK 0001894945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2022, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:08 UTC |
Erickson Stan K.Director
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027829 · rdgdoc.xml · nonDerivative · entry 1 Erickson Stan K. · CIK 0001626702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,817 F1 · shares: Restricted Stock scheduled to vest on June 1, 2022, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:07 UTC |
Fluet GregoryDirector
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027828 · rdgdoc.xml · nonDerivative · entry 1 Fluet Gregory · CIK 0001438939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2022, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:06 UTC |
Lee A JonesDirector
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027826 · rdgdoc.xml · nonDerivative · entry 1 Lee A Jones · CIK 0001374449 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,183 F1 · shares: Restricted Stock scheduled to vest on June 1, 2022, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:05 UTC |
Tune Kathleen ADirector
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027824 · rdgdoc.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2022, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:04 UTC |
Walsh Andrea M.Director
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027822 · rdgdoc.xml · nonDerivative · entry 1 Walsh Andrea M. · CIK 0001833129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2022, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 18:40 UTC |
MACCOURT MICHAEL JOSEPHChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,400 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0001437749-21-016495 · rdgdoc.xml · derivative · entry 2 MACCOURT MICHAEL JOSEPH · CIK 0001813112 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,400 Underlying: Common Stock · 7,400 shares Expires 2031-07-01 F1 · derivative.exercise_date: Stock options scheduled to vest in substantially equal increments on each of June 30, 2022, 2023 and 2024. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 18:40 UTC |
MACCOURT MICHAEL JOSEPHChief Financial Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-016495 · rdgdoc.xml · nonDerivative · entry 1 MACCOURT MICHAEL JOSEPH · CIK 0001813112 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 22:39 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,200 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0001437749-21-016493 · rdgdoc.xml · derivative · entry 3 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,200 Underlying: Common Stock · 18,200 shares Expires 2031-07-01 F1 · derivative.exercise_date: Stock options scheduled to vest in substantially equal increments on each of June 30, 2022, 2023 and 2024. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 22:39 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
GrantCommon Stock | 10,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-016493 · rdgdoc.xml · nonDerivative · entry 1 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,145 Read SEC document |
| June 10, 2021 Filed Aug 10, 2021 22:11 UTC |
Lee A JonesDirector
|
PurchaseCommon Stock | 1,000 | $11.06 | $11,060.00 |
DisclosureSEC source: 0001437749-21-019338 · rdgdoc.xml · nonDerivative · entry 1 Lee A Jones · CIK 0001374449 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,183 Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 16:55 UTC |
MACCOURT MICHAEL JOSEPHChief Financial Officer
|
PurchaseCommon Stock | 2,000 | $10.57 | $21,140.00 |
DisclosureSEC source: 0001437749-21-014257 · rdgdoc.xml · nonDerivative · entry 1 MACCOURT MICHAEL JOSEPH · CIK 0001813112 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 F1 · price: Reflects the weighted average price of 2,000 shares of common stock of Electromed, Inc. purchased by the reporting person in multiple transactions on June 3, 2021 with purchase prices ranging from $10.10 to $10.76 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:41 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
PurchaseCommon Stock | 5,000 | $9.87 | $49,350.00 |
DisclosureSEC source: 0001437749-21-012687 · rdgdoc.xml · nonDerivative · entry 1 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 5,000 Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:40 UTC |
SKARVAN KATHLEENDirector · President and CEO
|
PurchaseCommon Stock | 5,000 | $9.87 | $49,350.00 |
DisclosureSEC source: 0001437749-21-012686 · rdgdoc.xml · nonDerivative · entry 1 SKARVAN KATHLEEN · CIK 0001266296 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 5,000 Read SEC document |
| May 14, 2021 Filed May 20, 2021 00:25 UTC |
Craney Stephen H.Director
|
PurchaseCommon Stock | 10,000 | $9.35 | $93,455.00 |
DisclosureSEC source: 0001437749-21-012838 · rdgdoc.xml · nonDerivative · entry 1 Craney Stephen H. · CIK 0001504920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,901 F1 · price: Reflects the weighted average price of 10,000 shares of common stock of Electromed, Inc. purchased by the reporting person in multiple transactions on May 14, 2021 with purchase prices ranging from $9.25 to $9.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:22 UTC |
Winn George H.Director
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-024775 · rdgdoc.xml · nonDerivative · entry 1 Winn George H. · CIK 0001497809 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,388 F1 · shares: Restricted Stock scheduled to vest on June 1, 2021, unless earlier accelerated or terminated pursuant to their terms. F2 · balance_after: Reporting Person's beneficial ownership amount has been increased by 1,300 shares of common stock as a result of a reconciliation of his direct holdings against the amount set forth in his prior Form 4 filed on June 9, 2020. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:26 UTC |
Craney Stephen H.Director
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-024779 · rdgdoc.xml · nonDerivative · entry 1 Craney Stephen H. · CIK 0001504920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577,901 F1 · shares: Restricted Stock scheduled to vest on June 1, 2021, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.